We read with interest the manuscript by Ooi et al. Third, the optimal methodology to measure value across centers remains a challenge. Bacha (2) contends that cost data are "essentially arbitrary." Charging policies vary between hospitals, but cost-to-charge ratios are widely used to convert these charges into comparable costs. Until methods to measure cost to individual services are validated for our field, cost-to-charge ratios remain the only method for empirically measuring costs. Though not an optimal measure of value, the resultant costs are useful to: 1) measure differences in resource utilization and efficiency of care delivery between centers; and 2) integrate different aspects of outcome when comparing two treatment strategies. Cost is not a perfect measure of value, which is better quantified with marginal cost effectiveness. There are challenges to measuring quality of life in children, and quality-adjusted life-years or similar statistics have not been used in pediatric cardiology to date. It remains imperative for those invested in the field to work toward the development of validated measures of value including both economic cost and "quality."
study adds to mounting literature that transcatheter interventions represent superior value to surgery. However, it also raises several methodological issues that deserve further attention. Please note: Both authors have reported that they have no relationships relevant to the contents of this paper to disclose.
